Skip to main content

Meropenem Injection Shortage

Last Updated: May 17, 2016
Status: Resolved

Reason for the Shortage
    • BBraun had meropenem on shortage due to increased demand.
    • Fresenius Kabi states the reason for the shortage was increased demand.
    • Hospira has meropenem available.
    • Sandoz discontinued meropenem injection in January 2015.
    • AstraZeneca had Merrem on shortage due to increase demand.
Available Products
    • Merrem injection, AstraZeneca, 1 gram, vial, 10 count, NDC 00310-0321-30
    • Merrem injection, AstraZeneca, 500 mg, vial, 10 count, NDC 00310-0325-20
    • Meropenem injection, BBraun, 1 gm/50 mL, premixed bag, 24 count, NDC 00264-3185-11
    • Meropenem injection, BBraun, 500 mg/50 mL, premixed bag, 24 count, NDC 00264-3183-11
    • Meropenem injection, Fresenius Kabi, 1 gram, vial, 10 count, NDC 63323-0508-30
    • Meropenem injection, Fresenius Kabi, 500 mg, vial, 10 count, NDC 63323-0507-20
    • Meropenem injection, Pfizer, 1 gram, vial, 25 count, NDC 00409-3506-01
    • Meropenem injection, Pfizer, 500 mg, vial, 25 count, NDC 00409-3505-01

Estimated Resupply Dates

    • All marketed presentations are available.

Updated

Updated May 17, 2016 by Leslie Jensen, PharmD, Drug Information Specialist. Created August 6, 2015 by Jane Chandramouli, PharmD, Drug Information Specialist. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer